January 2012 Issue
Hyperspectral imaging can be used to optimize blending, by monitoring the distribution of excipients and APIs in formulation.
Changing from the status quo to meaningful testing will satisfy both FDA and ASTM.
MedImmunes approach may help take the blame off automation for plant startup delays.
Designing a new pharmaceutical manufacturing facility requires that architects and manufacturers collaborate to improve process flow.
There might be another way to increase output, reduce idle time or lower the average amount of material in a given linked set of processes.
Videoconferencing amongst manufacturing professionals is easing everything from tech transfer to troubleshooting.
A talk with Hydes Peter Watler about trends shaping biopharma facilities today and tomorrow.
FDA provides more direction as questions arise about dosage consistency.
Modularly constructed facilities are becoming less expensive, and more practical, for small and large drug manufacturers alike.
Modular construction and disposable process equipment are maximizing agility and minimizing risk
Zeta Interactive has published its annual end-of-year Buzz Report, recapping the most buzzworthy pharmaceutical brands trends and stories from 2011.
If not, maybe greed can help overcome manufacturings PR problem with young professionals.
Analysts say that 2012 may prove to be pharmas most challenging year ever.
Pharmaceutical machine vision technologies are getting simpler and cheaper, and yet tackling more varied applications.